dextrothyroxine has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adnan, M; Ashraf, SA; Badraoui, R; Chaubey, KK; Goyal, M; Hamadou, WS; Jahan, S; Jamal, A; Khan, MF; Sachidanandan, M; Sharma, P; Siddiqui, AJ; Snoussi, M | 1 |
| Chao, WY; Chen, SH; Lee, YR; Li, YZ; Shen, CH; Tung, CL; Wu, TY; Zhao, PW | 1 |
2 other study(ies) available for dextrothyroxine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against
Topics: Animals; Drug Repositioning; Humans; Ivermectin; Molecular Docking Simulation; Pharmaceutical Preparations; Schistosoma haematobium; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A | 2021 |
Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells.
Topics: Apoptosis; Carcinoma, Transitional Cell; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Ivermectin; JNK Mitogen-Activated Protein Kinases; Urinary Bladder Neoplasms | 2022 |